Rheumatic fever laboratory findings: Difference between revisions

Jump to navigation Jump to search
m (Changes made per Mahshid's request)
Line 33: Line 33:
===Biopsy of Endocardium===
===Biopsy of Endocardium===
Though [[endomyocardial biopsy]] may help in confirming the presence of [[carditis]], it is not recommended as a routine diagnostic and prognostic tool.<ref name="pmid8222115">{{cite journal| author=Narula J, Chopra P, Talwar KK, Reddy KS, Vasan RS, Tandon R et al.| title=Does endomyocardial biopsy aid in the diagnosis of active rheumatic carditis? | journal=Circulation | year= 1993 | volume= 88 | issue= 5 Pt 1 | pages= 2198-205 | pmid=8222115 | doi= | pmc= | url= }} </ref>
Though [[endomyocardial biopsy]] may help in confirming the presence of [[carditis]], it is not recommended as a routine diagnostic and prognostic tool.<ref name="pmid8222115">{{cite journal| author=Narula J, Chopra P, Talwar KK, Reddy KS, Vasan RS, Tandon R et al.| title=Does endomyocardial biopsy aid in the diagnosis of active rheumatic carditis? | journal=Circulation | year= 1993 | volume= 88 | issue= 5 Pt 1 | pages= 2198-205 | pmid=8222115 | doi= | pmc= | url= }} </ref>
There are no diagnostic laboratory findings associated with [disease name].
OR
An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].
OR
[Test] is usually normal among patients with [disease name].
OR
Laboratory findings consistent with the diagnosis of [disease name] include:
*[Abnormal test 1]
*[Abnormal test 2]
*[Abnormal test 3]
OR
Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].


==References==
==References==

Revision as of 19:14, 17 February 2020

Rheumatic fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rheumatic Fever from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Jones Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Case Studies

Case #1

Rheumatic fever laboratory findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rheumatic fever laboratory findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rheumatic fever laboratory findings

CDC on Rheumatic fever laboratory findings

Rheumatic fever laboratory findings in the news

Blogs on Rheumatic fever laboratory findings

Directions to Hospitals Treating Rheumatic fever

Risk calculators and risk factors for Rheumatic fever laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Varun Kumar, M.B.B.S. Anthony Gallo, B.S. [2]

Overview

Laboratory findings consistent with the diagnosis of rheumatic fever include elevated inflammatory markers, presence of streptococcal infection, and elevated or rising antistreptolysin O antibody titer.

Laboratory Findings

Inflammatory Markers

The following inflammatory markers are often elevated:

Throat Culture

Throat culture for group A beta-hemolytic streptococci may be performed. However many patients may have negative culture when rheumatic fever develops.[1]

Rapid Streptococcal Antigen

Rapid streptococcal antigen test may be performed. However, it has a lower sensitivity (70%) and statistically equal specificity (98%) as throat culture; a negative test results rules out streptococcal infection.[2]

Antistreptolysin O Antibody

Elevated or rising antistreptolysin O antibody titer is often noted. The antibodies usually peak approximately during fourth or fifth week after the onset of infection. Patients should be tested at intervals of two weeks to detect raising titers. Antistreptococcal antibodies may also be noted in patients who are streptococcal carriers with asymptomatic pharyngitis.

Leukocytosis

A marked leukocytosis is present.

C-Reactive Protein

An elevated C-reactive protein level is present.

Erythrocyte Sedimentation Rate

An elevated erythrocyte sedimentation rate is present.

Biopsy of Endocardium

Though endomyocardial biopsy may help in confirming the presence of carditis, it is not recommended as a routine diagnostic and prognostic tool.[3]


There are no diagnostic laboratory findings associated with [disease name].

OR

An elevated/reduced concentration of serum/blood/urinary/CSF/other [lab test] is diagnostic of [disease name].

OR

[Test] is usually normal among patients with [disease name].

OR

Laboratory findings consistent with the diagnosis of [disease name] include:

  • [Abnormal test 1]
  • [Abnormal test 2]
  • [Abnormal test 3]

OR

Some patients with [disease name] may have elevated/reduced concentration of [test], which is usually suggestive of [progression/complication].

References

  1. "Guidelines for the diagnosis of rheumatic fever. Jones Criteria, 1992 update. Special Writing Group of the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young of the American Heart Association". JAMA. 268 (15): 2069–73. 1992. PMID 1404745.
  2. Choby BA (2009). "Diagnosis and treatment of streptococcal pharyngitis". Am Fam Physician. 79 (5): 383–90. PMID 19275067.
  3. Narula J, Chopra P, Talwar KK, Reddy KS, Vasan RS, Tandon R; et al. (1993). "Does endomyocardial biopsy aid in the diagnosis of active rheumatic carditis?". Circulation. 88 (5 Pt 1): 2198–205. PMID 8222115.